leisure time -WSS

leisure time

author：fashion 2025-10-01 00:47:09 - browse：84667

The biotech company Acelyrin, which raised more than $500 million in an IPO this year, ran into its first major setback Monday as its investigational anti-inflammatory drug missed the primary goal in a pivotal clinical trial.

Acelyrin’s medicine, a subcutaneous treatment called izokibep, is meant to clear up lesions for patients with the common skin disease hidradenitis suppurativa, or HS, an inflammatory disorder that leads to abscesses and scars. But after 16 weeks of treatment, patients who received izokibep did not show significant improvements compared to those taking a placebo, failing the study’s primary endpoint.

Acelyrin’s share price fell more than 60% in after-hours trading Monday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Generate Biomedicines machine learning biotech raises $273M

leisure time

WSS

Food makers tried to stack nutrition panel with preferred experts

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Pig kidney works a record two months in donated body

Telehealth for opioid use disorder is lifesaving

A double vaccine crisis is endangering millions of children

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

focus

leisure time

focus

United colonoscopy coverage change 'may cost lives,' doctors say

How medical schools plan to diversify without affirmative action

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Regeneron agrees to White House price limits on anti

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How artificial intelligence is being used to detect, treat cancer

The cancer drug shortage isn’t new — and neither are the solutions

AbbVie dramatically boosts its spending on lobbying

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Court strikes down limits on filming of police in Arizona

Wikipedia

Diverse clinical trials: Why aren’t we there yet?

What to make of Biden’s latest efforts on cancer research

Caitlin Bernard's story shows physicians can't shy from advocacy

CDC backtracks, saying fully vaccinated people can go maskless indoors

Pig kidney works a record two months in donated body

Caitlin Bernard's story shows physicians can't shy from advocacy

leisure time

leisure time

leisure time

leisure time